Dr. Dennis Robert Grayson
My Social Links

Dr. Dennis Robert Grayson

Researcher
University of Illinois at Chicago, USA


Highest Degree
PostDoc. in Cell Biology from Rockefeller University, New York, USA

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Neuropharmacology
62%
Neuroscience
90%
Neuropsychopharmacology
75%
Molecular Pharamcology
55%

Research Publications in Numbers

Books
1
Chapters
11
Articles
181
Abstracts
10

Selected Publications

  1. Sharma, R.P., D.P. Gavin and D.R. Grayson, 2010. CpG methylation in neurons: Message, memory, or mask. Neuropsychopharmacol, 35: 2009-2020.
    CrossRef  |  PubMed  |  Direct Link  |  
  2. Grayson, D.R., M. Kundakovic and R.P. Sharma, 2010. Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders. Mol. Pharmacol., 77: 126-135.
    CrossRef  |  PubMed  |  Direct Link  |  
  3. Grayson, D.R., 2010. Schizophrenia and the epigenetic hypothesis. Epigenomics, 2: 341-344.
    CrossRef  |  PubMed  |  Direct Link  |  
  4. Dong, E., Y. Chen, D.P. Gavin, D.R. Grayson and A. Guidotti, 2010. Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics, 5: 730-735.
    CrossRef  |  PubMed  |  Direct Link  |  
  5. Kundakovic, M., Y. Chen, A. Guidotti and D.R. Grayson, 2009. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol. Pharm., 75: 342-354.
    CrossRef  |  PubMed  |  Direct Link  |  
  6. Guidotti, A., E. Dong, M. Kundakovic, R. Satta, D.R. Grayson and E. Costa, 2009. Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol. Sci., 30: 55-60.
    CrossRef  |  PubMed  |  Direct Link  |  
  7. Grayson, D.R., Y. Chen, E. Dong, M. Kundakovic and A. Guidotti, 2009. From trans-methylation to cytosine methylation: Evolution of the methylation hypothesis of schizophrenia. Epigenetics, 4: 144-149.
    PubMed  |  Direct Link  |  
  8. Gavin, D.P., C. Rosen, K. Chase, D.R. Grayson, N. Tun and R.P. Sharma, 2009. Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. J. Psychiatry Neurosci., 34: 232-237.
    PubMed  |  Direct Link  |  
  9. Costa, E., Y. Chen, E. Dong, D.R. Grayson and M. Kundakovic et al., 2009. GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability. Expert Rev. Neurother., 9: 87-98.
    CrossRef  |  PubMed  |  Direct Link  |  
  10. Sharma, R.P., N. Tun and D.R. Grayson, 2008. Depolarization induces downregulation of DNMT1 and DNMT3 in primary cortical cultures. Epigenetics, 3: 74-80.
    CrossRef  |  PubMed  |  Direct Link  |  
  11. Sharma, R.P., D.R. Grayson and D.P. Gavin, 2008. Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects; analysis of the National Brain Databank microarray collection. Schiophrenia Res., 98: 111-117.
    CrossRef  |  PubMed  |  Direct Link  |  
  12. Kharlamov, E.A., K.L. Downey, P.I. Jukkola, D.R. Grayson and K.M. Kelly, 2008. Expression of GABAA receptor α1 subunit mRNA and protein in rat neocortex following photothrombotic infarction. Brain Res., 1210: 29-38.
    CrossRef  |  PubMed  |  Direct Link  |  
  13. Gavin, D.P., S. Kartan, K. Chase, D.R. Grayson and R.P. Sharma, 2008. Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. Schizophrenia Res., 103: 330-332.
    CrossRef  |  PubMed  |  Direct Link  |  
  14. Dong, E., M. Nelson, D.R. Grayson, E. Costa and A. Guidotti, 2008. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc. Natl. Acad. Sci., 105: 13614-13619.
    CrossRef  |  PubMed  |  Direct Link  |  
  15. Ruzika, W., A. Zhubi, M. Veldic, D.R. Grayson, E. Costa and A. Guidotti, 2007. Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. Mol. Psychiatry, 12: 385-397.
    CrossRef  |  PubMed  |  Direct Link  |  
  16. Kundakovic, M., Y. Chen, E. Costa and D.R. Grayson, 2007. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol. Pharmacol., 71: 644-653.
    CrossRef  |  PubMed  |  Direct Link  |  
  17. Dong, E., A. Guidotti, D.R. Grayson and E. Costa, 2007. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc. Natl. Acad. Sci. USA., 104: 4676-4681.
    CrossRef  |  PubMed  |  Direct Link  |  
  18. Costa, E., E. Dong, D.R. Grayson, A. Guidotti, W. Ruzicka and M. Veldic, 2007. Reviewing the role of DNA (cytosine-5) methyltransferase overexpression in the cortical GABAergic dysfunction associated with psychosis vulnerability. Epigenetics, 2: 29-36.
    CrossRef  |  PubMed  |  Direct Link  |  
  19. Chen, Y., M. Kundakovic, R.C. Agis-Balboa, G. Pinna and D.R. Grayson, 2007. Induction of the reelin promoter by retinoic acid is mediated by Sp1. J. Neurochem., 103: 650-665.
    CrossRef  |  PubMed  |  Direct Link  |  
  20. Sharma, R.P., C. Rosen, S. Kartan, A. Guidotti, E. Costa, D.R. Grayson and K. Chase, 2006. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: Preliminary results from a clinical population. Schizophrenia Res., 88: 227-231.
    CrossRef  |  PubMed  |  Direct Link  |  
  21. Pinna, G., R.C. Agis-Balboa, A. Zhubi, K. Matsumoto, D.R. Grayson, E. Costa and A. Guidotti, 2006. Imidazenil and diazepam increase locomotor activity in mice exposed to protracted social isolation. Proc. Natl. Acad. Sci. USA., 103: 4275-4280.
    CrossRef  |  PubMed  |  Direct Link  |  
  22. Guidotti, A., W. Ruzicka, D.R. Grayson, M. Veldic, G. Pinna, J.M. Davis and E. Costa, 2006. S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport, 18: 57-60.
    CrossRef  |  PubMed  |  Direct Link  |  
  23. Grayson, D.R., Y. Chen, E. Costa, E. Dong, A. Guidotti, M. Kundakovic and R.P. Sharma, 2006. The human reelin gene: Transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacol. Ther., 111: 272-286.
    CrossRef  |  PubMed  |  Direct Link  |  
  24. Costa, E., E. Dong, D.R. Grayson, W. Ruzicka, M.V. Simonini, M. Veldic and A. Guidotti, 2006. Epigenetic targets in GABAergic neurons to treat schizophrenia. Adv. Pharmacol., 54: 95-117.
    PubMed  |  
  25. Tremolizzo, L., M.S. Doueiri, E. Dong, D.R. Grayson and G. Pinna et al., 2005. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry, 57: 500-509.
    CrossRef  |  PubMed  |  Direct Link  |  
  26. Sharma, R.P., D.R. Grayson, A. Guidotti, E. Costa, 2005. Chromatin, DNA methylation and neuron gene regulation-the purpose of the package. J. Psychiatry Neurosci., 30: 257-263.
    PubMed  |  Direct Link  |  
  27. Mitchell, C.P., Y. Chen, M. Kundakovic, E. Costa and D.R. Grayson, 2005. Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. J. Neurochem., 93: 483-492.
    CrossRef  |  PubMed  |  Direct Link  |  
  28. Guidotti, A., J. Auta, J.M. Davis, E. Dong and D.R. Grayson et al., 2005. GABAergic dysfunction in schizophrenia: New treatment strategies on the horizon. Psychopharmacology, 180: 191-205.
    CrossRef  |  PubMed  |  Direct Link  |  
  29. Grayson, D.R., X. Jia, Y. Chen, R.P. Sharma, C.P. Mitchell, A. Guidotti and E. Costa, 2005. Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. USA., 102: 9341-9346.
    CrossRef  |  PubMed  |  Direct Link  |  
  30. Gibbons, R.D., D.K. Bhaumik, D.R. Cox, D.R. Grayson, J.M. Davis and R.P. Sharma, 2005. Sequential prediction bounds for identifying differentially expressed genes in replicated microarray experiments. J. Stat. Plann. Inference, 129: 19-37.
    CrossRef  |  Direct Link  |  
  31. Dong, E., R.C. Agis-Balboa, M.V. Simonini, D.R. Grayson, E. Costa and A. Guidotti, 2005. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc. Natl. Acad. Sci. USA., 102: 12578-12583.
    CrossRef  |  PubMed  |  Direct Link  |  
  32. Veldic, M., H.M. Caruncho, W.S. Liu, J. Davis and R. Satta et al., 2004. DNA-Methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc. Natl. Acad. Sci. USA., 101: 348-353.
    CrossRef  |  PubMed  |  Direct Link  |  
  33. Noh, J.S., R.P. Sharma, M. Veldic, A.A. Salvacion and X. Jia et al., 2004. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proc. Natl. Acad. Sci. USA., 102: 1749-1754.
    CrossRef  |  PubMed  |  Direct Link  |  
  34. Costa, E., J. Davis, E. Dong, D.R. Grayson, A. Guidotti, L. Tremolizzo and M. Veldic, 2004. A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit. Rev. Neurobiol., 16: 1-23.
    CrossRef  |  PubMed  |  Direct Link  |  
  35. Costa, E., D.R. Grayson, C.P. Mitchell, L. Tremolizzo, M. Veldic and A. Guidotti, 2003. GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Crit. Rev. Neurobiol., 15: 121-142.
    PubMed  |